Breaking news

Amazon SAS Advances €4 Million Pharmaceutical Facility in Limassol

Amazon SAS has received the green light from the Environmental Authority to construct a state-of-the-art pharmaceutical manufacturing plant in Limassol, Cyprus. This ambitious €4 million project is set to be situated in the industrious Pentakomo-Monagroulli zone, precisely 620 meters southeast of Monagroulli village.

The construction timeline, as per the environmental impact assessment from September 2024, anticipates around ten months for completion, subject to any unexpected hurdles.

Details of the Facility

The expansive factory will cover 4,405 square meters over three levels. The underground level is designated for parking and auxiliary spaces, the second level will host pharmaceutical production, while the third level will accommodate offices and further auxiliary areas.

Notably, the plant will focus on solid pharmaceutical products like tablets and capsules, aiming for an annual output of 40 to 50 million units. Packaging will be diversified between bottles and blister packs, projecting an annual volume of approximately 10 million packaging units.

Infrastructure and Accessibility

The plant’s infrastructure includes multiple access points, with a controlled vehicle entrance, loading bay, and dedicated green spaces. A total of 50 parking spaces will cater to employees and visitors, ensuring accessibility options. The site will adhere strictly to health, safety, and environmental protocols in alignment with Cypriot and EU standards.

Strategic Significance

This development signifies a significant boost to the local economy, potentially paving the way for further industrial advancements in the region. For insights into how this project fits into broader economic trends, consider exploring Cyprus Housing Market Slows Amid Rising Costs and Regional Divergence.

CSE Reports March Market Shares As Argus Tops With 30.83%

Overview

Cyprus Stock Exchange (CSE) reported €31.50 million in share transactions for March 2026, including €11.24 million in pre-agreed trades. Data also cover the first quarter, with total transactions reaching €86.06 million across January to March.

Detailed Market Analysis

CSE provides market share calculations both including and excluding pre-agreed transactions. March figures incorporate these trades, while separate data sets highlight activity without them. Such differentiation reflects varying trading dynamics and offers a clearer view of market structure. Bond values are excluded from percentage calculations.

Quarterly Performance Metrics

Figures for the January–March period show how market shares shift depending on the calculation methodology. Year-to-date data provide a broader perspective on member activity across the exchange. Inclusion or exclusion of pre-agreed transactions affects comparative positioning. These metrics are used to assess overall performance trends.

Key Participant Performance

Argus Stockbrokers Ltd recorded a 30.83% market share in March, with transactions totaling €9.71 million, placing it first for the month. CISCO Ltd held a 24.54% share in March and ranked first for the quarter with 26.19%. Mega Equity Financial Services Ltd followed with 18.31% in March and 24.08% across the quarter. Additional participants included Eurobank EFG Equities with 8.04% and Atlantic Securities Ltd with 7.46%, contributing to overall market activity.

Aggregate Trading Volumes

Pre-agreed transactions accounted for €11.24 million of March’s total turnover. Overall trading value reached €86.06 million for the first quarter. These figures reflect both negotiated and regular market activity, providing a fuller picture of trading volumes.

Conclusion

CSE data outline the distribution of market shares and transaction volumes across members. Distinctions between pre-agreed and regular trades highlight differences in activity patterns. Reported figures provide a basis for evaluating market structure and participant performance.

Aretilaw firm
The Future Forbes Realty Global Properties
Uol
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter